Plasma biomarkers for lung cancer diagnosis
Active Cooperative Agreement Awarded Last action
- Award ID
- UH3CA251139
- Recipient
-
Biotarget DX LLC UEI XTERX9QBKVV7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,791,679
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date 94% complete
- Originally
- Place of performance
- Hanover, MD 21076, USA
Award details come from USAspending.gov.
Description
- Abstract
- Abstract because the early detection of lung cancer by low-dose CT (LDCT) can reduce the mortality, annual LDCT screening is now being reimbursed by centers for medicare & medicaid services (CMS) for smokers insured through medicare. However, more than one-quarter of screens discover indeterminate pulmonary nodules (PNS). 4% of PNS are early-stage lung cancers, while the remaining 96% are benign. Therefore, LDCT has over-diagnosis. There is an unmet need for a reflex test for LDCT follow-up to focus care on the 4% smokers need IT. The objective of this project is to develop and validate a plasma test for differentiating malignant from benign PNS at baseline LDCT. Future use of this test for discriminating between malignant and benign PNS will complement LDCT for lung cancer detection by reducing the over-diagnosis, and eventually decrease the deaths and cost.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $239,248 | |
| Amendment | $0 | |
| Amendment | $169,004 | |
| Amendment | -$237,375 | |
| Amendment | $317,792 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,445 | |
| Amendment | $1,445 | |
| Amendment | $1,445 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $324,669 | |
| Amendment | $324,669 | |
| Amendment | $324,669 | |
| Original award | $324,669 |
Show all 18
Quick answers
Who received award UH3CA251139?
UH3CA251139 was awarded to Biotarget DX LLC by National Cancer Institute (National Institutes of Health) on September 17, 2020.
How much is award UH3CA251139 worth?
$1,791,679 has been obligated on UH3CA251139.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award